King Andrew James bought JBIO
February 12, 2026 · Form 4 insider transaction
King Andrew James bought 41,250 shares of Jade Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
41,250
Price
$0.00
Total value
N/A
InsiderKing Andrew James
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2026
Filing dateFebruary 13, 2026
Shares owned after386,113
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). 1/4 of the total number of RSUs granted shall vest on each of the first four anniversaries of February 15, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.